General Announcement::Approval of Clinical Trials for PNH of Innovative Drug Complement Factor B Inhibitor CMS-D017

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Securities
CHINA MEDICAL SYSTEM HLDGS LTD - KYG211081248 - 8A8
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Jan-2026 19:27:38
Status
New
Announcement Sub Title
Approval of Clinical Trials for PNH of Innovative Drug Complement Factor B Inhibitor CMS-D017
Announcement Reference
SG260130OTHRF0S8
Submitted By (Co./ Ind. Name)
Wu Sanyan
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

CMS-Approval of Drug Clinical Trials for PNH Indication of Innovative Drug Complement Factor B Inhibitor CMS-D017.pdf
Total size =164K